Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksZYDUSLIFE
resources
ZYDUSLIFE

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE
BSE: 532321
Sector: Healthcare
Industry: Pharmaceuticals
1,148.00-5.0 (-0.43%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Zydus Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Zydus Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2026
  • Newspaper Publication4 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper cutting dated July 4, 2026 with regard to Notice and information of 31st Annual General Meeting of the Company published in the Financial Express.
  • Press Release / Media Release3 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release
  • Acquisition29 Jun 2026
    Announcement under Regulation 30 (LODR)-Updates on Acquisition
    Update on acquisition of API business
  • Joint Venture26 Jun 2026
    Announcement under Regulation 30 (LODR)-Joint Venture
    Joint Venture in Sri Lanka
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Intimation of Trading Window Closure
  • General20 Jun 2026
    Disclosures Under SEBI (Prohibition Of Insider Trading) Regulations, 2015
    Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Buy back19 Jun 2026
    Corporate Action-Updates on Buy back
    Extinguishment Certificate
  • Buy back18 Jun 2026
    Corporate Action-Updates on Buy back
    Post Buyback Public Advertisement
  • General16 Jun 2026
    Completion Of Merger Of Assertio Holdings Inc.
    Completion of merger of Assertio Holdings Inc.
  • Press Release / Media Release16 Jun 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Zydus announces the successful completion of acquisition of Assertio Holdings.
  • Newspaper Publication11 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication of notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati Editions, both on June 11, 2026.
  • General9 Jun 2026
    Intimation Of Drop In GST Demand
    Intimation of drop in GST demand
  • Newspaper Publication3 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Copy of newspaper publication
  • General3 Jun 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Receipt of Warning Letter from USFDA for Baddi facility
  • Buy back1 Jun 2026
    Corporate Action-Updates on Buy back
    Revised Letter of Offer
  • Buy back31 May 2026
    Corporate Action-Updates on Buy back
    Letter of Offer
  • Press Release / Media Release28 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Zydus Therapeutics'' New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA.
  • Buy back28 May 2026
    Corporate Action-Updates on Buy back
    Newspaper publication of addendum to public announcement
  • Buy back27 May 2026
    Corporate Action-Updates on Buy back
    Addendum to the Public Announcement for the Buyback of equity shares

Frequently Asked Questions

Where can I download the annual report of Zydus Lifesciences Ltd.?
Annual reports of Zydus Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Zydus Lifesciences Ltd.?
Quarterly earnings results and presentations of Zydus Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Zydus Lifesciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Zydus Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Zydus Lifesciences Ltd.?
Investor presentations and annual day presentations of Zydus Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Zydus Lifesciences Ltd.?
Corporate announcements and regulatory filings of Zydus Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Zydus Lifesciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Zydus Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Zydus Lifesciences Ltd.?
The ISIN (International Securities Identification Number) of Zydus Lifesciences Ltd. is INE010B01027. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Zydus Lifesciences Ltd. listed?
Zydus Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is ZYDUSLIFE and the BSE code is -.
Where can I find the shareholding pattern of Zydus Lifesciences Ltd.?
The quarterly shareholding pattern of Zydus Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Zydus Lifesciences Ltd. on Sharpely?
Share price data for Zydus Lifesciences Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.